Ludwig C - Search Results

1

Evidence for selection of homogeneously staining regions in a human melanoma cell line.

Trent JM, Thompson FH, Ludwig C. Trent JM, et al. Among authors: ludwig c. Cancer Res. 1984 Jan;44(1):233-7. Cancer Res. 1984. PMID: 6197160

2

Cellular and genetic properties of two melanoma cell lines established from the same tumor.

Ludwig C, Harper J, Payne C, Nagle R, Bastert G, Trent J. Ludwig C, et al. Anticancer Res. 1988 Jan-Feb;8(1):9-16. Anticancer Res. 1988. PMID: 3358643

3

Tumor growth stimulation in vitro by interferons.

Ludwig CU, Durie BG, Salmon SE, Moon TE. Ludwig CU, et al. Eur J Cancer Clin Oncol. 1983 Nov;19(11):1625-32. doi: 10.1016/0277-5379(83)90095-0. Eur J Cancer Clin Oncol. 1983. PMID: 6580172

4

The calcium-binding protein calretinin-22k is detectable in the serum and specific cells of cancer patients.

Schwaller B, Meyer-Monard S, Gander JC, Pugin P, Celio MR, Ludwig C. Schwaller B, et al. Among authors: ludwig c. Anticancer Res. 1998 Sep-Oct;18(5B):3661-7. Anticancer Res. 1998. PMID: 9854474

5

Cytotoxicity of mitomycin C on clonogenic human carcinoma cells is not enhanced by hypoxia.

Ludwig CU, Peng YM, Beaudry JN, Salmon SE. Ludwig CU, et al. Cancer Chemother Pharmacol. 1984;12(3):146-50. doi: 10.1007/BF00256535. Cancer Chemother Pharmacol. 1984. PMID: 6423304

6

Effect of leukocyte interferons on cell proliferation of human tumors in vitro.

Ludwig CU, Durie BG, Salmon SE, Moon TE. Ludwig CU, et al. Recent Results Cancer Res. 1984;94:220-3. doi: 10.1007/978-3-642-82295-7_23. Recent Results Cancer Res. 1984. PMID: 6208584 No abstract available.

7

[OKT-8+ suppressor T-lymphocytes are increased in patients with stable multiple myeloma].

Ludwig C, Hicks MJ, Pena D, Durie BG. Ludwig C, et al. Schweiz Med Wochenschr. 1983 Oct 8;113(40):1451-4. Schweiz Med Wochenschr. 1983. PMID: 6227989 German.

8

Evidence for transcriptional repression of SPARC-like 1, a gene downregulated in human lung tumors.

Isler SG, Ludwig CU, Chiquet-Ehrismann R, Schenk S. Isler SG, et al. Int J Oncol. 2004 Oct;25(4):1073-9. Int J Oncol. 2004. PMID: 15375558

9

Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial.

Hess V, Salzberg M, Borner M, Morant R, Roth AD, Ludwig C, Herrmann R. Hess V, et al. Among authors: ludwig c. J Clin Oncol. 2003 Jan 1;21(1):66-8. doi: 10.1200/JCO.2003.04.029. J Clin Oncol. 2003. PMID: 12506172 Clinical Trial.

10

Reduced bisantrene-induced cytotoxicity and protein-associated DNA strand breaks under hypoxic condition.

Ludwig CU, Bowden GT, Roberts RA, Alberts DS. Ludwig CU, et al. Cancer Treat Rep. 1984 Feb;68(2):367-72. Cancer Treat Rep. 1984. PMID: 6697326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

802 results

Search Page